New research into age-related immune failure, Alzheimer’s treatment also benefits autistic children, a stable vaccine for malaria, and more!
By Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
New research into age-related immune failure
In lab tests on aging and the immune system, biologists at Israel’s Ben Gurion University have profiled over 24,000 T-Cells. They identified that 30% deteriorate during the aging process and could establish new areas of medical intervention to prevent age-related illnesses.
Alzheimer’s treatment also benefits autistic children
Israeli researchers at Sheba Medical Center have found that a medication used to treat Alzheimer’s patients also has strong therapeutic effects on autistic children. 60 such children were given Donepezil and Cholin for six months and their language skills improved significantly.
A stable vaccine for malaria
Malaria kills half-a-million people annually. In this “Weizmann in Focus” video, Dave Doneson explains that current anti-malaria vaccines break down in hot climates. However, scientists at Israel’s Weizmann Institute redesigned the protein RH5 to enable the vaccine to be stored at room temperature.
Preventing secondary brain tumors
Up to 40% of cancer patients develop secondary brain tumors shortly after surgery to remove a primary tumor elsewhere in the body. Researchers at Tel Aviv University have shown that an intravenous injection of CpG-C (synthetic DNA material) can prevent these metastases forming.
Software to monitor cancer patients at home
I reported previously (see here) on Israeli startup Telesofia when it developed personalized medical videos. Now Israel’s Sheba Medical Center is to pilot Telesofia’s tele-medicine software for cancer patients at home to communicate with doctors about chemotherapy side effects.
US approval for blood pressure wristband monitor
Israel’s Biobeat develops wireless products (wristwatch and patch) to measure blood pressure, oxygenation, pulse, stroke volume and more. Both items sync data to the cloud, enabling remote monitoring. The US FDA has just given clearance to the combined products.
Hope for multiple myeloma patients
Thanks to Israeli discoveries and research, patients with the bone marrow cancer multiple myeloma are leading longer, better lives.